0 Yorumlar
0 hisse senetleri
73 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Class I Innovative Drug — Deuterated Enzalutamide Soft Capsules Approved for Market Launch!A Breakthrough in China’s Prostate Cancer Treatment with a Homegrown Innovation!According to information obtained from the official website of Hong Kong DengYue Medicine, the Class I innovative drug Haina’an® (generic name: Deuterated Enzalutamide Soft Capsules) has been approved for marketing in China.This therapy is indicated for adult patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with...0 Yorumlar 0 hisse senetleri 469 Views 0 önizleme
-
Metastatic Castrate Resistant Prostate Cancer Treatment Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Metastatic Castrate Resistant Prostate Cancer Treatment Market : The global metastatic castrate resistant prostate cancer treatment market size was valued at USD 11.99 billion in 2024 and is expected to reach USD 22.37 billion by 2032, at a CAGR of 8.10% during the forecast period This Metastatic Castrate Resistant Prostate Cancer...0 Yorumlar 0 hisse senetleri 687 Views 0 önizleme
-
Metastatic Castrate Resistant Prostate Cancer Treatment Market Future Scope: Growth, Share, Value, Size, and Analysis"The global metastatic castrate resistant prostate cancer treatment market size was valued at USD 11.99 billion in 2024 and is expected to reach USD 22.37 billion by 2032, at a CAGR of 8.10% during the forecast period The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make...0 Yorumlar 0 hisse senetleri 375 Views 0 önizleme
-
Metastatic Castrate Resistant Prostate Cancer Treatment Market Leaders: Growth, Share, Value, Size, and Scope"Executive Summary Metastatic Castrate Resistant Prostate Cancer Treatment Market : The global metastatic castrate resistant prostate cancer treatment market size was valued at USD 11.99 billion in 2024 and is expected to reach USD 22.37 billion by 2032, at a CAGR of 8.10% during the forecast period A credible Metastatic Castrate Resistant...0 Yorumlar 0 hisse senetleri 866 Views 0 önizleme
-
Automotive Regenerative Braking System Market Future Scope: Growth, Share, Value, Size, and Analysis"In-Depth Study on Executive Summary Automotive Regenerative Braking System Market Size and Share The Global Automotive Regenerative Braking System Market size was valued at USD 31.3 Billion in 2024 and is expected to reach USD 47.2 billion by 2032, at a CAGR of 6.0% during the forecast period Automotive Regenerative Braking System Market research...0 Yorumlar 0 hisse senetleri 41K Views 0 önizleme
-
Industrial Crane Market Companies: Growth, Share, Value, Size, and InsightsThe Global Industrial Crane Market size was valued at USD 51.77 billion in 2024 and is expected to reach USD 83.39 billion by 2032, at a CAGR of 6.14% during the forecast period The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic decisions. One segment seeing...0 Yorumlar 0 hisse senetleri 11K Views 0 önizleme